NeuraLight

AI-driven Platform for Digitizing Neurology

Health Tech & Life Sciences
Active
Series A Tel Aviv-Yafo Founded 2021
Total raised
$30.5M
Last: Series A 2022-05
Stage
Series A
Founded
2021
Headcount
39
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

NeuraLight is building an AI-driven platform to accelerate and improve drug development, monitoring, and care for patients with neurological disorders by using information captured with a standard smartphone or webcam. The companys platform automatically extracts micro-oculometrics, providing objective and sensitive digital markers for neurological disorders. The solution is designed to serve as a robust proxy for currently used endpoints and to ultimately define a new measurement standard, paving the path for precision medicine in neurology. NeuraLight is focused on transforming the lives of the billions of people impacted by neurological disorders by digitizing patient evaluation and care. Its vision is a world where neurological disorders can be prevented, diagnosed, and treated effectively so that people can live longer, healthier lives.

Funding history · 2 rounds · $30.5M total

2022-05
Series A $25.0M
2021-10
Seed $5.5M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was NeuraLight founded and where is its headquarters located?
NeuraLight was founded in February 2021 and is headquartered in Tel Aviv-Yafo, Israel.
What is NeuraLight's primary focus in the healthcare sector?
NeuraLight is building an AI-driven platform to accelerate and improve drug development, monitoring, and care for patients with neurological disorders.
How does NeuraLight's platform gather data for neurological disorder assessment?
NeuraLight's platform uses information captured with a standard smartphone or webcam to automatically extract micro-oculometrics, providing digital markers for neurological disorders.
What was NeuraLight's initial funding round and when did it occur?
NeuraLight raised $5.5 million in Seed funding in October 2021, with MS&AD Ventures as a lead investor.
When did NeuraLight complete its Series A funding round and who was a lead investor?
NeuraLight completed its Series A funding round in May 2022, raising $25 million with Koch Disruptive Technologies as a lead investor.
What is the total amount of funding NeuraLight has raised to date?
NeuraLight has raised a total of $30.5 million across its Seed and Series A funding rounds. For a full financing history, please refer to startupim.
How many employees does NeuraLight currently have?
NeuraLight currently has 39 employees.
What was a notable collaboration for NeuraLight in July 2022?
In July 2022, NeuraLight collaborated with NeuroSense Therapeutics to detect ALS using AI.
What new assessment tool was reported in April 2023 involving NeuraLight's technology?
In April 2023, a new assessment tool for ALS based on abnormal eye movements, utilizing NeuraLight's technology, was reported.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceComputer VisionDeep Learning
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B

Tags

degenerative-diseasesalzheimers-diseasevideohealthcare-providersparkinsondeep-learningautomationpharma-companiesdrug-developmentcomputer-visiondiagnosticssignal-processingartificial-intelligencemultiple-sclerosisweb-platformdigital-healthcaredecision-supportmobile-applicationstelemedicineneurology